eTable 7. Sensitivity analysis of the second primary endpoint EQ-5D-5L—full model in the per-protocol population.
Group comparison team-based − standard | |||
Model coefficient* | 95% confidence interval | p value | |
(Intercept) | 0.43 | [0.31; 0.55] | < 0.001 |
Baseline EQ-5D-5L | −0.41 | [−0.48; −0.34] | < 0.001 |
Male sex | 0.05 | [0.01; 0.09] | 0.018 |
Age (per 10 years) | −0.03 | [−0.04; −0.01] | 0.001 |
Neu form of care | 0.02 | [−0.01; 0.05] | 0.206 |
Psoriatic arthritis | 0.00 | [−0.48; 0.48] | 0.937 |
* estimated using a linear mixed model with the variables listed and with a random center effect EQ-5D-5L, EuroQol in 5 dimensions and 5 response levels.